Related Experiment Videos
Persistent hyperplastic primary vitreous: diagnosis, treatment and results
1Department of Ophthalmology, Scottish Rite Children's Hospital, Atlanta, USA.
Transactions of the American Ophthalmological Society
|January 1, 1997
Summary
Persistent hyperplastic primary vitreous (PHPV) treatment offers hope for useful vision, especially with anterior-only cases. Early intervention can save the eye from glaucoma and phthisis, improving visual outcomes.
Area of Science:
- Ophthalmology
- Pediatric Ophthalmology
- Surgical Innovation
Background:
- Persistent hyperplastic primary vitreous (PHPV) is a congenital eye condition that can lead to severe vision impairment.
- Untreated PHPV can result in devastating complications such as glaucoma and phthisis bulbi.
- Early diagnosis and intervention are crucial for managing PHPV and preserving ocular health.
Observation:
- A significant percentage of patients with anterior PHPV achieved 20/200 or better vision (71.4%) with treatment.
- Successful visual outcomes (20/70 or better) were exclusively observed in eyes with purely anterior PHPV.
- Bilaterality of PHPV presented a very poor prognosis for vision, with affected patients having only light perception or hand motion vision.
Findings:
- Surgical intervention, including lensectomy and membrane removal, is vital for preventing secondary glaucoma and phthisis.
- The extent of the PHPV membrane is the most critical prognostic factor for visual outcomes.
- While saving the eye is achievable, obtaining useful vision is highly dependent on the anterior-only presentation of PHPV.
Implications:
- Families of infants with anterior PHPV can be counseled about the good prognosis for useful vision with surgical and amblyopia therapies.
- For posterior or combined anterior-posterior PHPV, the focus of treatment should be on preventing eye loss, with visual recovery being less likely.
- Further research into managing complex PHPV cases and improving binocular vision outcomes is warranted.